375 results on '"Jóźwiak, Katarzyna"'
Search Results
52. Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
53. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
54. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
55. RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients Response
56. Power Analysis for Trials With Discrete-Time Survival Endpoints
57. Cost-effective designs for trials with discrete-time survival endpoints
58. Immune Dysregulation in Pediatric Common Variable Immunodeficiency: Implications for the Diagnostic Approach
59. Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
60. Sex Differences in Clinical Course and Intensive Care Unit Admission in a National Cohort of Hospitalized Patients with COVID-19
61. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy
62. Response to Klar and Adams
63. Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
64. Czas to motoneuron. Wyzwania systemowe i rekomendacje w opiece nad pacjentami z SMA w Polsce. Time is a motoneuron. System challenges and recommendations in the care of patients with SMA in Poland
65. Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
66. A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer
67. Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
68. Change in cognition before and after non‐central nervous system cancer diagnosis: A population‐based cohort study
69. Increasing Biogas Yield from Fodder by Microbial Stimulation of Propionic Acid Synthesis in Grass Silages
70. Concept of improving shipping processes on a selected example
71. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour : A systematic review and meta-analysis
72. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: A systematic review and meta-analysis
73. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour:a systematic review and meta-analysis
74. Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial
75. A Phase I dose‐escalation study of two cycles carboplatin‐olaparib followed by olaparib monotherapy in patients with advanced cancer
76. Everyday nonconvulsive status epilepticus episodes in a 12-year-old girl with pharmacoresistant epilepsy of unknown etiology admitted for presurgical evaluation
77. Interstitial lung disease and bronchiectasis in children with primary immunodeficiencies: a single-centre experience
78. Adjuvant Capecitabine-Containing Chemotherapy Benefit and Homologous Recombination Deficiency Status Among Early-Stage TNBC Patients in the FinXX trial
79. Optimal Designs for Event History Analysis
80. Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
81. Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial
82. Abstract P5-02-05: Variability in ductal carcinoma in situ grading among an international group of pathologists
83. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis
84. Selective IgA deficiency – does partial mean negligible?
85. Brain structure prior to non-central nervous system cancer diagnosis: A population-based cohort study
86. Cutaneous and systemic granulomatosis in ataxia-telangiectasia: a clinico-pathological study
87. Comparing in vivo and ex vivo fiberoptic diffuse reflectance spectroscopy in colorectal cancer
88. Stwardnienie guzowate.
89. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
90. Comparing in vivo and ex vivo fiberoptic diffuse reflectance spectroscopy in colorectal cancer
91. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
92. Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria
93. Influence of neoadjuvant chemotherapy on diffuse reflectance spectra of tissue in breast surgery specimens
94. Platinum exposure and cause‐specific mortality among patients with testicular cancer
95. Trajectories of Cognitive Function Prior to Cancer Diagnosis: A Population-Based Study
96. Neural modeling of the truck vehicle operation system
97. Imaging depth variations in hyperspectral imaging: Development of a method to detect tumor up to the required tumor‐free margin width
98. EZH2 Is Overexpressed in BRCA1-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy
99. ISSUES OF THE SELECTION OF VEHICLES FOR TASKS IN COMPANIES
100. Nusinersen for spinal muscular atrophy - results of an expanded access programme (P4.4-012)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.